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Inferior vena cava graft-enteric fistula after
extended hepatectomy with caval replacement
Pietro Addeo, MD, Edoardo Rosso, MD, Elie Oussoultzoglou, MD, Daniel Jaeck, MD, PhD, FRCS,
Patrick Pessaux, MD, PhD, and Philippe Bachellier, MD, Strasbourg, France
A case of an inferior vena cava (IVC) graft-enteric fistula manifesting with recurrent sepsis 11 years after a right hepatectomy
extending to segments I and IV, the extrahepatic bile duct, and IVC followed by chemotherapy and external-beam radiation
therapy is described. A preoperative workup revealed graft thrombosis with air bubbles inside the lumen. Laparotomy found
a chronic fistula between the graft and the enteric biliary loop. Removal of the graft without further vascular reconstruction,
a take-down of the biliary loop, and a redo hepaticojejunostomy were performed successfully. The diagnostic challenges,
possible etiology, and therapeutic implications of this case are discussed. (J Vasc Surg 2012;55:226-9.)
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sBecause of the major improvements in surgical tech-
niques and intraoperative management, liver resection ex-
tended to the inferior vena cava (IVC) is currently per-
formed with limited mortality and acceptable postoperative
morbidity.1-5 Given the poor results of nonsurgical treat-
ments, aggressive surgical resection combined with postop-
erative adjuvant treatment improves the overall survival and
provides a cure for carefully selected patients with primary
IVC tumors or IVC involvement by liver malignancies.
Because of the small size and the short follow-up of the
series that have been previously reported, little is known
about long-term infectious complications after such an
extreme surgery.4,6-8 Herein, we describe the case of an
enteric-IVC graft fistula after an extended liver resection
with caval replacement performed 11 years earlier. We
discuss the diagnostic challenges, possible etiology, and
therapeutic implications of this case.
CASE REPORT
A 75-year-old woman was referred to our center with a
2-year-long history of recurrent sepsis occurring 11 years after a
right hepatectomy extending to segments I and IV9 combined
with resection of the extrahepatic bile duct, suprarenal tract of the
IVC, and lymphadenectomy for an intrahepatic cholangiocarci-
noma. The suprarenal tract of the IVC, extending from above the
renal vein confluence to immediately below the left hepatic vein
insertion, was replaced with a 7-cm-long, externally supported
expanded polytetrafluoroethylene (ePTFE) graft (20 mm in diam-
eter; Fig 1, A-C). A 60-cm-long Roux-en-Y hepaticojejunostomy
was used for the biliary reconstruction. Pathology revealed a T3
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2260 intrahepatic cholangiocarcinoma, and postoperative chemo-
herapy and external beam irradiation were administered for 6
onths. Nine years later, the patient presented with six episodes of
epsis that were characterized by chills, rigor, fever, and tachycardia
nd required several hospital admissions over an 18-month period.
vidence for several digestive tract bacteria, including E. coli and
nterobacter cloacae, was disclosed via several blood cultures. Dur-
ng each episode, intravenous broad-spectrum antibiotic coverage
nd bowel rest were adopted, with a complete remission of the
linical signs. The radiological workup, including magnetic reso-
ance imaging (MRI), computed tomography (CT), blood mar-
ow aspiration, radiography of the maxillary sinus, and 99-mTc
eukoScan (Immunomedics, New Plains, NJ) scintigraphy failed
o localize the source of the septicemia. During the last septic
pisode, an abdominal CT scan revealed the complete thrombosis
f the ePTFE graft, with some air bubbles inside the lumen (Fig 1,
). The patient was then referred to our center for treatment.
pon admission, she denied nausea, vomiting, hematemesis, and
elena, and no signs of edema in the lower extremity were present
uring the physical examination. A laboratory test revealed mild
eukocytosis and normal renal and liver function. A radiological
orkup confirmed the complete thrombosis of the ePTFE graft
nd normal liver outflow through the left hepatic vein-IVC con-
uence and renal venous outflow maintained via the retroperito-
eal collateral circulation (Fig 2,A). An infected thrombosis of the
VC graft was suspected, and its removal was planned. Surgery was
erformed through a bilateral subcostal incision with an upper
idline extension. The hepatic pedicle was isolated and taped. A
omplete thrombosis extending from the renal vein confluence to
he upper end of the IVC graft was found. The IVC was isolated,
repared, and taped below the renal vein confluence and into its
ntrapericardial portion via a diaphragmatic window. Dissection
ound a chronic fistula between the biliary loop and the ePTFE
raft. After clamping both ends of the IVC and administering
ystemic heparin, the PTFE conduit was removed en bloc along
ith 10 cm of the biliary loop. The hepatic end of the IVC was
ound to be completely closed due to the dense fibrous tissue. A
hrombectomy of the two renal veins was performed, and both the
nds of the IVC were closed with running polypropylene 4/0
utures. A redo hepaticojejunostomy on the liver biliary ducts for
egments II and III (protected by two external transanastomotic-
ransjejunal stents) was performed. The surgery lasted 380 min-
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The postoperative course was complicated by respiratory distress,
which required ventilatory support. The patient was discharged
home at postoperative day 30 in good general condition. Two
months later, her symptoms completely disappeared, and an MRI
revealed normal liver and kidney outflow (Figs 2, B-D and 3).
During her 2-year follow-up, the patient developed an anasto-
motic stenosis of 1 bilioenteric anastomosis, which was treated by
percutaneous dilation. Two years later, sepsis has not recurred.
DISCUSSION
Aggressive surgical management, combining liver and
IVC resection, can provide long-term survival in carefully
selected patients with primary IVC tumors or IVC involve-
ment by liver malignancies.10 As of 2006, only 78 cases of
hepatectomies with IVC reconstruction by PTFE or Da-
cron grafts have been described,11 and no cases of graft-
enteric fistula have been reported.2-6,10-11
In cases of IVC resection-replacement, autologous
veins (pericardial or vein patches) or aortic homografts can
be used due to their low thrombosis and infection rates.12
Dacron or PTFE conduits represent the most commonly
used prosthetic materials.13 Reinforced ePTFE grafts are
widely available, can be sized to precisely match the caliber
of the IVC, and have the advantage of being resistant to
compression by overlying viscera. Due to these character-
istics, ePTFE grafts have good durability when using only
low-dose aspirin10 or subcutaneous postoperative heparin.3
Fig 1. A, Preoperative computed tomography (CT) sc
invasion. B, Cavography confirmed caval infiltration w
postoperative CT scan revealed normal graft patency.D,
with some air bubbles inside the lumen (black arrow).For this graft, the necessity of a long-term oral anticoagu- fant is not universally accepted,11 with some authors using
raft arterialization to enhance its patency (between either
he remaining left renal vessels or right renal artery and the
omolateral gonadic vein).14,15
The diagnosis of fistula between the IVC and the
igestive tract can be based on the association between
igestive bleeding and septic syndromes.16 However, these
wo conditions rarely occur simultaneously, and their diag-
oses can be particularly difficult.16,17 Endoscopy can be
sed to explore the upper digestive tract, but, when an
xcluded biliary loop is present, its value remains limited.
T or MRI can help identify graft thrombosis and gas
ithin the ePTFE conduit and evaluate liver and renal
ascular outflow. Cavography remains fundamental, espe-
ially when the IVC is inadequately imaged by CT and
RI.4 Several factors could have contributed to the devel-
pment of the graft-enteric fistula described here. Proper
solation of the PTFE graft from the nearby structure by an
mental wrap should be systematically adopted.2,4,11 In
ur case, its absence probably facilitated the immediate
dherence between the graft and the digestive tract. The
ubsequent adherence of the jejunal loop to the PTFE graft
n an irradiated field predisposed the bowel to ulceration,
ransmural penetration, fistula formation, sepsis, and sec-
ndary graft thrombosis.7,8,18 Alternatively, formation of a
hick neointima4 and the characteristics of the PTFE graft
ould have been the cause of the thrombosis, and fistula
owing a large tumor with an inferior vena cava (IVC)
he development of collateral circulation. C, A 2-year
graft had completely thrombosed 11 years after surgery,an sh
ith t
Theormation could have been delayed, as suggested by the
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(MRI) scan showing retroperitoneal collateral circulation via the lum
hepatic vein; IVC, inferior vena cava;RA, right atrium.
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In conclusion, recurrent septicemia manifesting after
ynthetic vena cava replacement should strongly suggest
rosthetic infection and prompt referral to an experienced
enter for treatment. Prosthesis ablation without further
ascular reconstruction can be performed when collateral
enous circulation is present, as in our case.19 The surgeons
nd physicians involved in the care of patients undergoing
uch an extreme surgery should be aware of this potentially
ethal complication and be very suspicious when patients
resent with a fever or sepsis of unknown origin.
The authors would like to thank Sophie Riehm, MD,
or providing the radiological illustration of this article.
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As the authors point out, there have been only a few dozen
cases of hepatectomies with inferior vena cava (IVC) reconstruc-
tion described in the literature, and this case report may be the first
to describe a graft-enteric fistula. In the surgical oncology world,
we have witnessed progressive aggressiveness in liver tumor resec-
tion. The ability to perform successfully these hepatectomies with
concomitant IVC resection/reconstruction has depended in part
on the evolution of better intraoperative equipment – energy
devices and staplers for more efficient dissection and transaction of
the liver parenchyma. In select hepatobiliary centers, these cases of
hepatectomies with IVC resection/reconstruction may be consid-
ered on some routine basis. It remains unclear which patients may
likely benefit from this radical surgery.
I agree with the authors that the most relevant factors for the
likely cause of this fistula would be the radiation therapy and the
absence of an omental wrap. The routine use of an omental wrap
between the IVC graft and the enteric limb is centrally important
to significantly reduce the risk of fistula formation. Hepatobiliary
surgeons are quite aware of the common recurrences of cholangitis
after any biliary reconstruction. The presence of a synthetic graft
should compel much more liberal consideration for antibiotics and
earlier diagnostic studies to look for graft infection and fistula.
Although I am eager to see comparison studies that may
demonstrate comparable or better long-term patency rates andequire radiation treatment in that field, I do realize that such
omparison is difficult to perform due to the rarity of this condi-
ion.
As the technology advances, along with our abilities to
iagnose and manage such relatively rare but very complex
omplications, it would be our shared onus – between vascular
urgeons and hepatobiliary surgeons – to be that much more
elective of the patients to consider such radical resections. The
ifficulty of such diagnosis and surgical treatment of these fistulas is
specially challenging in the present era of more itinerant surgeon
ross-coverage, superspecialization, and more geographically mo-
ile patients. Such circumstances require heightened awareness as
rovided by these journal reports and additional longitudinal
tudies.
Looking forward, I anticipate that many future patients who
evelop such fistulas may not be so fortunate to have a similar
ndolent course as this reported patient (2-year history of recurrent
epsis, 11 years of survival from the original tumor resection), with
uch chronicity as to allow sufficient collateralization to avoid
econstruction at the time of fistula repair. The typical patient in
he community who develops such a fistula may be more likely to
uccumb to acute sepsis or graft blow out. I believe that there
ould be a significant self-selection, that these fistulas would take
long time to develop, and, therefore, only a small number of liver
ancer survivors (with original tumors so locally aggressive as to
equire IVC resection) would present with fistula formation.
